Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria
Pathogens · 2024
DOI: 10.3390/pathogens13090797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Jingyi Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzho…. Hauptthemen laut MEDLINE: Antimicrobial Cationic Peptides, Drug Resistance, Multiple, Bacterial, Escherichia coli, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Jiangsu Province (Modern Agriculture), Key R&D Program of Jiangsu Province (Modern Agriculture), Hainan Province Science and Technology Special Fund.
Abstract (Originalsprache)
The accelerating spread of antibiotic resistance has significantly weakened the clinical efficacy of existing antibiotics, posing a severe threat to public health. There is an urgent need to develop novel antimicrobial alternatives that can bypass the mechanisms of antibiotic resistance and effectively kill multidrug-resistant (MDR) pathogens. Antimicrobial peptides (AMPs) are one of the most promising candidates to treat MDR pathogenic infections since they display broad-spectrum antimicrobial activities and are less prone to achieve drug resistance. In this study, we investigated the antibacterial capability and mechanisms of two machine learning-driven linear peptide compounds termed YI12 and FK13. We reveal that YI12 and FK13 exhibit broad-spectrum antibacterial properties against clinically significant bacterial pathogens, inducing no or minimal hemolysis in mammalian red blood cells. We further ascertain that YI12 and FK13 are resilient to heat and acid-base conditions, and exhibit susceptibility to hydrolytic enzymes and divalent cations under physiological conditions. Initial mechanistic investigations reveal that YI12 and FK13 compromise bacterial membrane integrity, leading to membrane potential dissipation and excessive reactive oxygen species (ROS) generation. Collectively, our findings highlight the prospective utility of these two cationic amphiphilic peptides as broad-spectrum antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
- Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
- Institute of Comparative Medicine, Yangzhou University, Yangzhou 225009, China.
ORCID-Profile: Jingyi Sun, Yuan Liu
Förderung
- Key R&D Program of Jiangsu Province (Modern Agriculture)
- Key R&D Program of Jiangsu Province (Modern Agriculture)
- Hainan Province Science and Technology Special Fund
- Jiangsu Agricultural Science and Technology Innovation Fund
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- 111 Project D18007
Zitieren
APA
Sun, J., Kong, P., Shi, J., & Liu, Y. (2024). Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria. Pathogens. https://doi.org/10.3390/pathogens13090797
Vancouver
Sun J, Kong P, Shi J, Liu Y. Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria. Pathogens. 2024. doi:10.3390/pathogens13090797
BibTeX
@article{Sun2024,
author = {Sun, Jingyi and Kong, Pan and Shi, Jingru and Liu, Yuan},
title = {Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13090797}
}
EUVIMED